Saga Research Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.40 M
as on 16-11-2024
- Revenue 18.42%
(FY 2023)
- Profit 9.83%
(FY 2023)
- Ebitda 13.77%
(FY 2023)
- Net Worth 111.95%
(FY 2023)
- Total Assets 23.33%
(FY 2023)
About Saga Research Laboratories
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.40 M.
Rakesh Sajjan and Aditi Gupta serve as directors at the Company.
- CIN/LLPIN
U73100MH2020PTC345192
- Company No.
345192
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Saga Research Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Sajjan  | Director | 03-Sep-2020 | Current |
| Aditi Gupta | Director | 03-Sep-2020 | Current |
Financial Performance of Saga Research Laboratories.
Saga Research Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.42% increase. The company also saw a slight improvement in profitability, with a 9.83% increase in profit. The company's net worth Soared by an impressive increase of 111.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saga Research Laboratories?
Unlock access to Saga Research Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Konark Herbals And Healthcare Private LimitedActive 3 years 6 monthsRakesh Sajjan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Aug 2023 | ₹4.40 M | Open |
How Many Employees Work at Saga Research Laboratories?
Saga Research Laboratories has a workforce of 103 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saga Research Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saga Research Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
